NCT03536793 2026-03-18
TEM-PAC
Hull University Teaching Hospitals NHS Trust
Recruiting
Clinical Trials
447 trialsNCT05636514 2026-03-18
CELESTIAL-MDS
Clinical Hub for Interventional Research (CHOIR)
Phase 1 Recruiting
NCT07470840 2026-03-17
SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT07477912 2026-03-17
MSTH-CAR001
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
Phase 1/2 Recruiting
NCT07472140 2026-03-16
PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer
N.N. Alexandrov National Cancer Centre
Phase 2/3 Recruiting
NCT07472153 2026-03-16
PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer
N.N. Alexandrov National Cancer Centre
Phase 2/3 Recruiting
NCT07472621 2026-03-16
Real-World Effectiveness and Safety of Glofitamab in Primary Refractory and Early Relapsed Diffuse Large B-Cell Lymphoma
Henan Cancer Hospital
Not yet recruiting
NCT07284953 2026-03-13
PuraBond
The Royal Wolverhampton Hospitals NHS Trust
Phase NA Withdrawn
NCT07469306 2026-03-13
Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT07470294 2026-03-13
PiloPedia
University Hospital, Angers
Not yet recruiting
NCT07465497 2026-03-12
Impact of Supplementation With Synbiotics and Prebiotics on Cognitive Decline Associated With Neoadjuvant Chemotherapy in First-line Patients With Breast Cancer
Instituto Jalisciense de Cancerologia
Phase NA Enrolling by invitation
NCT07467330 2026-03-12
Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment
Fujian Cancer Hospital
Phase 3 Recruiting
NCT06990659 2026-03-11
CHOC
University Hospital, Angers
Phase NA Recruiting
NCT07463976 2026-03-11
TITLE CLL
The Royal Wolverhampton Hospitals NHS Trust
Not yet recruiting
NCT07464769 2026-03-11
KompXX
Region Jönköping County
Phase NA Not yet recruiting
NCT03877029 2026-03-09
Long-term Effects of Breast Cancer Treatment
Norwegian Institute of Public Health
Completed
NCT06704659 2026-03-09
RAY-no-BAN
Turku University Hospital
Phase NA Recruiting
NCT05440838 2026-03-06
BioPredictor
University Hospital, Angers
Recruiting
NCT06248450 2026-03-06
YouCanPrefer
Linkoeping University
Phase NA Completed
NCT07191418 2026-03-06
Spearmint
Region Västerbotten
Phase NA Not yet recruiting
NCT07453628 2026-03-06
Association of Erectile Dysfunction With Neuropathic Pain, Disease Activity, and Functional Status in Male Patients With Axial Spondyloarthritis: A Cross-Sectional Observational Study
Bursa City Hospital
Completed
NCT07448545 2026-03-05
Turkish Version of the UCLA Prostate Cancer Index
Lokman Hekim University
Completed
NCT07451743 2026-03-05
ACL ALL
ASL Lecce
Phase NA Not yet recruiting
NCT06787183 2026-03-03
SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases
Fujian Cancer Hospital
Phase 2 Recruiting
NCT07445386 2026-03-03
Transdiscal vs Paravertebral Neurolytic Splanchnic Nerve Block for Upper Abdominal Cancer Pain
Ankara Etlik City Hospital
Phase NA Recruiting
NCT07445451 2026-03-03
TURBT
Dr. Lutfi Kirdar Kartal Training and Research Hospital
Phase NA Completed
NCT07435623 2026-03-02
Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study
Tata Memorial Hospital
Recruiting
NCT07441785 2026-03-02
PROXISTAT
P. Herzen Moscow Oncology Research Institute
Recruiting
NCT07442890 2026-03-02
A Cohort Study on the Prevention of Nausea and Vomiting Induced by Concurrent Chemoradiotherapy for Lung Cancer Using Rolapitant and Palonosetron
Henan Cancer Hospital
Phase NA Not yet recruiting
NCT07435025 2026-02-27
Surgery for Obstructed Gastric Carcinoma
Zagazig University
Phase NA Active not recruiting
NCT06839157 2026-02-25
Artificial Intelligence - Assisted Model for Optimal Timing of Surgery in Advanced Ovarian Cancer
Shanghai Gynecologic Oncology Group
Active not recruiting
NCT07425379 2026-02-24
Prehabilitation in Breast Cancer Surgery
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Phase NA Not yet recruiting
NCT03005743 2026-02-23
COMBAT-Cx
Tata Memorial Hospital
Phase NA Completed
NCT06104371 2026-02-23
SentiNeo2
Vastra Gotaland Region
Recruiting
NCT05102240 2026-02-20
Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer
Tata Memorial Hospital
Recruiting
NCT06264167 2026-02-20
NODE
Queensland Centre for Gynaecological Cancer
Phase NA Recruiting
NCT06644846 2026-02-20
Spatially Fractionated Radiation Treatment for Gynaecological Cancers
Tata Memorial Hospital
Phase NA Recruiting
NCT06996483 2026-02-20
FUSION
Ankara Etlik City Hospital
Recruiting
NCT07083271 2026-02-20
FIN-CARE
Ankara Etlik City Hospital
Completed
NCT07162675 2026-02-20
NEOBRE-STEP
Ankara Etlik City Hospital
Recruiting
NCT07184047 2026-02-20
TOX-FRAIL
Ankara Etlik City Hospital
Completed
NCT07415291 2026-02-19
CNN-Based AI Versus Physicians for Solitary Skin Lesion Diagnosis
Istanbul Training and Research Hospital
Active not recruiting
NCT07416253 2026-02-18
Trastuzumab Rezetecan vs Trastuzumab Deruxtecan in the Neoadjuvant Treatment of HER2 Positive Breast Cancer
Henan Cancer Hospital
Phase 2 Not yet recruiting
NCT03997110 2026-02-17
RAPPAL
Tata Memorial Hospital
Phase NA Recruiting
NCT05875870 2026-02-17
Effects of Bright-light Exposure Combined With Specific Exercise Training (BEST) Program in Patients With Cancer
Taipei Veterans General Hospital, Taiwan
Phase NA Recruiting
NCT07400809 2026-02-17
Retro-COSMOS
Tata Memorial Hospital
Recruiting
NCT04081428 2026-02-13
PRINToUT
NHS Lothian
Active not recruiting
NCT04690972 2026-02-12
LivMOD
Institut National de la Santé Et de la Recherche Médicale, France
Recruiting
NCT05316181 2026-02-12
KOV-HIPEC-02R
National Cancer Center, Korea
Phase 3 Active not recruiting
NCT05954416 2026-02-12
FARD
Institut National de la Santé Et de la Recherche Médicale, France
Recruiting